Shanghai ChemPartner Co., Ltd. and Agios Pharmaceuticals Expand Cancer Drug Collaboration
7/10/2009 11:22:57 AM
More...
|
Shanghai ChemPartner Co., Ltd. and Agios Pharmaceuticals Expand Integrated Drug Discovery Research Collaboration
7/9/2009 8:45:24 AM
More...
|
Agios Pharmaceuticals' Focus of Drug Research – Cancer Metabolism – Selected for Stand Up To Cancer Grant
5/28/2009 8:31:42 AM
More...
|
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO
5/27/2009 7:15:57 AM
More...
|
Agios Pharmaceuticals' Founders Author Science Review on Cancer Metabolism
5/21/2009 12:33:44 PM
More...
|
Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at American Association for Cancer Research
4/30/2009 9:00:09 AM
More...
|
Agios Pharmaceuticals Appoints Charles Sawyers, M.D., to Scientific Advisory Board
2/6/2009 8:19:54 AM
More...
|
Agios Pharmaceuticals Expands Into 21,000 SqFt Facility
11/24/2008 8:36:12 AM
More...
|
Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team
11/24/2008 8:34:27 AM
More...
|
Agios Pharmaceuticals Closes $33 Million Series A Funding
7/7/2008 6:34:07 AM
More...
|